Gleicher, Norbert http://orcid.org/0000-0002-0202-4167
Mochizuki, Lyka
Barad, David H.
Patrizio, Pasquale
Orvieto, Raoul
,
Article History
Received: 14 December 2022
Accepted: 22 February 2023
First Online: 9 March 2023
Declarations
:
: Not applicable.
: N.G. and D.H.B. are listed as co-owners of several already awarded and still pending U.S. patents, some claiming benefits from androgen supplementation in women with low functional ovarian reserve. Others relate to the diagnostic and potential therapeutic benefits of AMH. N.G. is a shareholder in Fertility Nutraceuticals and is the owner of the CHR, a fertility center in New York City. N.G. and D.H.B. also receive patent royalties from Fertility Nutraceuticals, LLC. N.G. and P.P. also received research support, travel funding, and lecture fees from various Pharma and medical device companies, none, however, over the last three years and none in any way related to this manuscript. Other authors have no conflicts to report.